Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-07-29 Interim / Quarterly Rep…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2021 HY report - final_29-07-21 - NL.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Halfjaarlijks Financieel Verslag 2021' (Half-Yearly Financial Report 2021) for the period ending June 30, 2021. It contains comprehensive financial statements, including consolidated balance sheets, income statements, cash flow statements, and detailed management commentary on performance. It is not an announcement or a summary, but the full interim report itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-07-29 Dutch
210723 - Disposals of own shares_ENG final.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details the transaction of UCB shares OTC due to the exercise of stock options under Long Term Incentive Plans. This activity specifically relates to the company buying back or issuing shares as part of compensation/incentive schemes, which falls under the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a direct announcement of these transactions, not an announcement of a report, so RPA/RNS is not the primary classification.
2021-07-23 English
210723 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA disposed of its own shares following the exercise of stock options by employees as part of long-term variable compensation. This directly corresponds to the definition of a company reporting transactions involving its own shares, specifically share repurchase or issuance, which maps to the 'Transaction in Own Shares' category (POS). The document is a formal regulatory disclosure (indicated by the reference to the Royal Decree and the date/time stamp) detailing these specific transactions.
2021-07-23 French
210723 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details the number of UCB shares disposed of (transferred) on specific dates due to the exercise of employee stock options under various LTI plans. This transaction type, where a company deals with its own shares (repurchases or issuance/disposal related to compensation plans), directly corresponds to the definition of 'Transaction in Own Shares'. The filing is explicitly marked as 'gereglementeerde informatie' (regulated information), confirming its official nature. Therefore, the appropriate code is POS.
2021-07-23 Dutch
210716 - Disposals of own shares_ENG final.pdf
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Disposals of own shares" and details transactions where the company disposed of its own shares OTC following stock option exercises related to employee incentive programs. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing code POS is the most appropriate match.
2021-07-16 English
210716 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA alienated (sold/issued) its own shares following the exercise of employee stock options. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal announcement dated July 16, 2021, detailing specific transactions that occurred between July 2 and July 15, 2021. It is not a general regulatory filing (RNS) or a report publication announcement (RPA) because it contains the substantive data itself, not just a notice that a report is available.
2021-07-16 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.